Diagnostic value of inflammatory biomarkers of ESR and CRP in differentiating severe and moderate cases of COVID-19 patients hospitalized in Shahid Beheshti Hospital in Kashan, Iran, in 2021

Razaghi, Reza; Momen_Heravi, Mansooreh; Faghihi, Reihaneh; Nahri, Hamidreza; Fallahzadeh, Mohammdhasan; Azadchehr, Mohammad Javad; Razaghi, Mohammad Javad

doi:10.48307/FMSJ.2023.27.4.360

[Home ] [Archive]

[ فارسی ]

Main Menu

Home

Journal Information

Indexing Sources

Guide for Authors

Online Submission

Ethics

Articles archive

For Reviewers

Contact us

Basic and Clinical Biochemistry and Nutrition

DOAJ

CINAHL

EBSCO

IMEMR

ISC

Search in website

Receive site information

enamad

Volume 27, Issue 4 (Bimonthly 2023)

Feyz Med Sci J 2023, 27(4): 360-367

Back to browse issues page

Diagnostic value of inflammatory biomarkers of ESR and CRP in differentiating severe and moderate cases of COVID-19 patients hospitalized in Shahid Beheshti Hospital in Kashan, Iran, in 2021

Reza Razaghi

, Mansooreh Momen_Heravi ^*

, Reihaneh Faghihi

, Hamidreza Nahri

, Mohammdhasan Fallahzadeh

, Mohammad Javad Azadchehr

, Mohammad Javad Razaghi

Infectious Diseases Research Center, Kashan University of Medical Sciences, Kashan. Iran , mansoreheravi@yahoo.com

Abstract: (1624 Views)

Background and Aim: The levels of inflammatory biomarkers ESR and CRP are significantly increased in the early stages of the COVID-19 and their levels are related to the severity of the disease. The present study was conducted to determine the diagnostic value of CRP and ESR in COVID-19.
Methods: This cross-sectional study was conducted on 287 patients with COVID-19 hospitalized in Shahid Beheshti Hospital in Kashan, Iran, in 2021. A questionnaire containing demographic data, clinical symptoms, laboratory findings and final outcome was completed by reviewing the medical records and HIS system. Patients were divided into moderate and severe groups according to the severity of lung involvement in CT scan and oxygen saturation (SPO₂). The data were entered into SPSS-16 software and the ESR and CRP levels were compared between the two groups. Moreover, the sensitivity, specificity, positive and negative predictive values, and the cut-off point were determined and the ROC curve was drawn.
Results: Out of 287 patients, 151 (52.6%) were women and 136 (47.4%) were men, and the mean age of the patients was 56.14±18.45 years. Hypertension (35.5%) was the most common underlying disease. Shortness of breath (56.8%) and cough (52.3%) were the most common clinical symptoms. In this study, 34.1% of the patients had a severe form of the disease. Finally, 18 patients (6.3%) died. ESR test with a cut-off point of 30, sensitivity of 81.6%, and specificity of 71.4% and CRP test with a cut-off point of 38, sensitivity of 84.7%, and specificity of 82.5% have the necessary accuracy to diagnose the severity of COVID-19.
Conclusion: According to the current findings, ESR with a cut-off point of 30 and CRP with a cut-off point of 38 had the necessary diagnostic accuracy to assess the severity of COVID-19. Therefore, in the initial examination of COVID-19 patients, according to the cut-off point of these two important biomarkers, severe cases of the disease should be quickly identified and the necessary treatment measures should be started as soon as possible to prevent poor outcomes.

Keywords: Diagnostic value, ESR, CRP, Cut-off point, COVID-19

Full-Text [PDF 442 kb] (958 Downloads)

Type of Study: Research | Subject: medicine, paraclinic
Received: 2023/09/14 | Revised: 2024/04/3 | Accepted: 2023/09/23 | Published: 2023/10/23

References

1. Guide to the diagnosis and treatment of Covid-19 at the levels of providing outpatient and inpatient services. 12th. 2023 Ministry of Health, Treatment and Medical Education.

2. Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. Jama. 2020; 323(18): 1843-4 doi:10.1001/jama.2020.3786 PMid:32159775 PMCid:PMC7066521

3. Zeng F, Huang Y, Guo Y, Yin M, Chen X, Xiao L, Deng G. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. Int J Infect Dis. 2020; 96: 467-474 doi:10.1016/j.ijid.2020.05.055 PMid:32425643 PMCid:PMC7233226

4. Ghahramani S, Tabrizi R, Lankarani KB, Kashani SMA, Rezaei S, Zeidi N, et al. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res. 2020; 25(1):30. doi:10.1186/s40001-020-00432-3 PMid:32746929 PMCid:PMC7396942

5. Elshazli RM, Toraih EA, Elgaml A, El-Mowafy M, El-Mesery M, Amin MN, et al. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients. PLoS One 2020; 15(8): e0238160. doi:10.1371/journal.pone.0238160, PMid:32822430 PMCid:PMC7446892

6. Ji P, Zhu J, Zhong Z, Li H, Pang J, Li B, Zhang J. Association of elevated inflammatory markers and severe COVID-19: A meta-analysis. Medicine (Baltimore). 2020;99(47):e23315. doi:10.1097/MD.0000000000023315 PMid:33217868 PMCid:PMC7676531

7. Izcovich A, Ragusa MA, Tortosa F, Marzio MAL, Agnoletti C, Bengolea A, et al. PLoS One. 2022 17(5): e0269291. doi:10.1371/journal.pone.0269291 PMid:35617192 PMCid:PMC9135219

8. Smilowitz NR, Kunichoff D, Garshick M, Shah B, Pillinger M, Hochman JS, et al. C-reactive protein and clinical outcomes in patients with COVID-19. Eur Heart J. 2021;42(23):2270-9 doi:10.1093/eurheartj/ehaa1103, PMid:33448289 PMCid:PMC7928982

9. Tan C, Huang Y, Shi F, Tan K, Ma Q, Chen Y, et al. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early. J Med Virol. 2020;92(7):856-62 doi:10.1002/jmv.25871 PMid:32281668 PMCid:PMC7262341

10. Pathak A, Agrawal A. Evolution of C-Reactive Protein. Front Immunol. 2019;10:943. doi:10.3389/fimmu.2019.00943, PMid:31114584 PMCid:PMC6503050

11. Lapić I, Rogić D, Plebani M. Erythrocyte sedimentation rate is associated with severe coronavirus disease 2019 (COVID-19): a pooled analysis. Clin Chem Lab Med. 2020;58(7):1146-1148. doi:10.1515/cclm-2020-0620, PMid:32386190

12. Bao J, Li C, Zhang K, Kang H, Chen W, Gu B. Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19. Clin Chim Acta. 2020;509:180-94. doi:10.1016/j.cca.2020.06.009, PMid:32511971 PMCid:PMC7274996

13. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730-41 doi:10.1111/all.14238, PMid:32077115

14. Wang G, Wu C, Zhang Q, Wu F, Yu B, Lv J, et al. C-Reactive Protein Level May Predict the Risk of COVID-19 Aggravation. Open Forum Infect Dis. 2020;7(5):153. doi:10.1093/ofid/ofaa153, PMid:32455147 PMCid:PMC7197542

15. Sadeghi-Haddad-Zavareh M, Bayani M, Shokri M, Ebrahimpour S, Babazadeh A, Mehraeen R, et al. C-Reactive Protein as a Prognostic Indicator in COVID-19 Patients. Interdiscip Perspect Infect Dis. 2021; 2021: 5557582. doi:10.1155/2021/5557582, PMid:33968148 PMCid:PMC8083820

16. Chen W, Zheng KI, Liu S, Yan Z, Xu C, Qiao Z. Plasma CRP level is positively associated with the severity of COVID-19. Ann Clin Microbiol Antimicrob. 2020; 19(1): 18. doi:10.1186/s12941-020-00362-2 PMid:32414383 PMCid:PMC7227180

17. Lapić I, Rogić D, Plebani M. Erythrocyte sedimentation rate is associated with severe coronavirus disease 2019 (COVID-19): a pooled analysis. Clin Chem Lab Med. 2020; 58(7):1146-1148. doi:10.1515/cclm-2020-0620 PMid:32386190

Send email to the article author

Add your comments about this article

‎ 10.48307/FMSJ.2023.27.4.360

Mendeley

Zotero

RefWorks

Razaghi R, Momen_Heravi M, Faghihi R, Nahri H, Fallahzadeh M, Azadchehr M J et al . Diagnostic value of inflammatory biomarkers of ESR and CRP in differentiating severe and moderate cases of COVID-19 patients hospitalized in Shahid Beheshti Hospital in Kashan, Iran, in 2021. Feyz Med Sci J 2023; 27 (4) :360-367
URL: http://feyz.kaums.ac.ir/article-1-4985-en.html

This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.

Volume 27, Issue 4 (Bimonthly 2023)

Back to browse issues page

Persian site map - English site map - Created in 0.17 seconds with 46 queries by YEKTAWEB 4704